The TEST Act aims to close loopholes in clinical trial registration and results reporting. It would require registration and results reporting for all interventional studies, regardless of phase, design, or approval status. This would provide a more complete public record of clinical trials and their results. The Act also mandates registration and reporting of foreign trials used to support FDA applications. Overall, the TEST Act furthers the goal of conducting clinical research transparently and ensuring trial participants see the benefits of their contributions.